首页> 外文会议>Eastern Nutrition Conference >Dairy Cow Ketosis: Novel Biomarkers for Early Detection of DiseaseRisk
【24h】

Dairy Cow Ketosis: Novel Biomarkers for Early Detection of DiseaseRisk

机译:乳制品牛酮动酶:新型生物标志物,用于早期检测失败病

获取原文

摘要

The incidence rate of periparturient diseases of dairy cows in Canada and elsewhere has increased steadily during the last two decades. In fact, the number of culled cows per dairy herd, per year in Canada has reached more than 50% with metritis, mastitis, and laminitis leading the list. Ketosis also is a major disease of dairy cows given its high incidence rate. Ketosis has been defined as a metabolic disturbance of energy metabolism that affects subclinically more than 40% of periparturient dairy cows in a herd. Another 12-15% of the cows are affected by the clinical form of the disease. This becomes economically important when taking into consideration the impact that both subclinical and clinical forms of ketosis have on the incidence rate of other periparturient diseases and in lowering milk yield. Presently, diagnosis of ketosis is performed by measurement of ketone bodies in various body fluids with blood P-hydroxy-butyric acid (BHBA) as the golden standard. Cows diagnosed with ketosis are treated with solutions containing dextrose or glucose and glucocorticoids aiming to normalize blood glucose and lower ketone bodies. Moreover, antibiotics like monensin have been approved to be used in Canada as feed additives to prevent occurrence of ketosis; however, this has raised concerns of bacterial resistance. Given the side effects of antibiotics, other more natural preventative treatments would be desirable to be developed and used in the future. However, since not all transition dairy cows areaffected by ketosis it would be beneficial to diagnose cows at greater risk of developing ketosis at an earlier stage and treat only those cows with preventative interventions. This necessitates identification and application of new tests that can diagnose cows at risk of developing ketosis at the earliest possible stage of disease. Recently our lab has applied metabolomics technologies to identify new metabolite signatures that are able to indicate with very high sensitivity and specificity dairy cowsat risk of developing ketosis at the beginning of dry off period. These new biomarker sets of ketosis can be used in the future to identify and treat cows at risk of developing ketosis at the earliest possible stage, prior to elevation of ketone bodiesin body fluids. In this article we also will discuss a paradigm switch that is happening with regards to the methodology and the philosophy that the animal science and veterinary scientists are using in approaching the studying of causality and pathomeachisms of disease around parturition.
机译:在过去的二十年中,加拿大奶牛和其他地方的乳制品母牛群体疾病发病率稳步增长。事实上,每年在加拿大每年的牛奶牛群的数量达到了50%以上,头孢菌炎,乳腺炎和领导列表。刺激也是奶牛的主要疾病,鉴于其发病率高。酮症被定义为能量代谢的代谢干扰,这些能量代谢在牧群中潜在过亚泼特乳制品奶牛的亚泼氏菌群。另外12-15%的奶牛受到疾病的临床形式的影响。考虑到临床和临床形式对其他围髋疾病的发生率和降低牛奶产量的影响,这在经济上是重要的重要性。目前,通过用血液p-羟基 - 丁酸(BHBA)的各种体液中的酮体测量酮体作为黄金标准来进行刺激剂的诊断。患有刺激病的母牛用含有葡萄糖或葡萄糖和糖皮质激素的溶液治疗,旨在标准化血糖和下酮体。此外,像Monensin这样的抗生素已被批准用于加拿大作为饲料添加剂以防止发生酮症;然而,这提出了对细菌抗性的担忧。鉴于抗生素的副作用,其他更自然的预防性治疗是希望在未来开发和使用的。然而,由于并非所有的过渡乳制品奶牛面积为酮症,因此诊断奶牛会在早期阶段诊断奶牛的风险是有益的,并且仅治疗具有预防性干预的那些奶牛。这需要鉴定和应用新的测试,可以在最早可能的疾病阶段诊断患有刺激性的风险。最近,我们的实验室已经应用了代谢组科技术,以确定能够在干燥期初表​​示具有非常高的敏感性和特异性乳制品奶牛风险的新的代谢物签名。在未来,这些新的生物标志物组的酮症术可以在未来鉴定和治疗在酮体血液液体液体升高之前在最早的可能阶段开发酮症的风险。在本文中,我们还将讨论一个范式,即在动物科学和兽医科学家正在接近分娩周围疾病的因果关系和病态主义的研究中使用的方法和哲学正在发生的范式。

著录项

  • 来源
    《Eastern Nutrition Conference》|2017年|238 p. ;|共10页
  • 会议地点
  • 作者

  • 作者单位
  • 会议组织
  • 原文格式 PDF
  • 正文语种
  • 中图分类 S815-532;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号